Omnipod 5 Insulin Delivery Pod Injury Lawsuit Lawyers

Manufacturing Defect in Insulin Delivery Pods May Cause Insulin Leaks and Dangerous Blood Sugar Spikes

A recall involving insulin delivery pods used in the Omnipod 5 Automated Insulin Delivery System has raised significant concerns among patients who rely on the technology to manage diabetes. Insulet Corporation announced a voluntary recall affecting certain lots of these pods after identifying a manufacturing defect that could interfere with proper insulin delivery.

What Parker Waichman LLP Found

• Certain Omnipod 5 insulin pods may contain tears in the internal insulin delivery tubing
• Insulin leaks inside the pod can prevent proper insulin delivery to patients
• At least 18 serious adverse events involving high blood glucose have been reported
• Persistent high blood glucose can lead to diabetic ketoacidosis, a life-threatening condition
• Patients injured by defective insulin delivery devices may have the right to file a lawsuit

According to safety information shared by the U.S. Food and Drug Administration, some pods may contain a small tear in the internal tubing responsible for transporting insulin from the pod into the body. When this defect occurs, insulin can leak inside the device rather than being delivered through the infusion system.

For patients living with diabetes, the consequences of improper insulin delivery can be severe. Insulin regulates blood glucose levels, and when insulin does not reach the bloodstream as intended, blood sugar levels may rise quickly. Persistent high blood glucose levels can trigger serious complications that require urgent medical treatment.

The FDA has confirmed that at least eighteen serious adverse events linked to elevated blood glucose levels have already been reported in connection with this manufacturing issue.

When a medical device designed to manage a life-threatening condition fails to function properly, patients may face immediate health risks. Individuals who experienced complications related to defective Omnipod pods may have legal rights under product liability laws.

How the Omnipod 5 Automated Insulin Delivery System Works

The Omnipod 5 system represents one of the most advanced insulin delivery technologies currently available for people managing diabetes. It was cleared by the FDA for use by individuals with both type 1 and type 2 diabetes.

Unlike traditional insulin therapy that requires multiple injections per day, the Omnipod system provides automated insulin delivery through a wearable pod. The system works through continuous communication between three components:

• A wearable insulin pod
• A continuous glucose monitoring sensor (CGM)
• A smartphone-based control application

The pod itself is worn directly on the skin and filled with rapid-acting insulin. Each pod can hold up to 200 units of insulin and is designed to deliver medication for approximately three days before needing replacement.

During normal operation, the CGM tracks glucose levels in real time. The system then automatically adjusts insulin delivery based on the patient’s current glucose readings. This automated process helps maintain more stable blood sugar levels and reduces the need for manual injections.

Because the device operates continuously and without constant manual oversight, reliability is critical. Even small malfunctions can disrupt insulin therapy and lead to dangerous fluctuations in blood glucose levels.

The Manufacturing Defect That Triggered the Recall

The recall was initiated after Insulet identified a defect in the manufacturing process affecting certain lots of Omnipod 5 pods.

The problem involves a tear in the internal tubing that transports insulin from the pod reservoir into the patient’s body. This tubing is a vital component of the delivery system. If the tubing is compromised, insulin may leak inside the pod rather than entering the infusion pathway.

When this occurs, several problems may arise:

• Insulin may not reach the bloodstream as programmed
• Blood glucose levels may increase unexpectedly
• The patient may not immediately realize insulin delivery has failed
• Prolonged high blood sugar can occur before the malfunction is detected

Because insulin therapy often requires precise dosing, even short interruptions can affect blood glucose levels significantly. A hidden leak inside the device may allow insulin to accumulate within the pod while the patient unknowingly receives little or none of the intended dose.

This situation can become particularly dangerous overnight or when patients rely heavily on the automated system to maintain glucose control.

Health Risks Linked to Improper Insulin Delivery

The most serious health risk associated with defective Omnipod pods is the development of dangerously high blood glucose levels, also known as hyperglycemia.

Hyperglycemia can cause symptoms such as:

• Extreme thirst
• Frequent urination
• Fatigue
• Blurred vision
• Nausea and vomiting
• Shortness of breath

If high blood glucose persists, the condition may progress to diabetic ketoacidosis (DKA). DKA occurs when the body cannot use glucose for energy due to insufficient insulin. As a result, the body begins breaking down fat, producing acids called ketones.

High ketone levels can lead to a medical emergency. Symptoms of diabetic ketoacidosis may include:

• Severe dehydration
• Confusion
• Rapid breathing
• Abdominal pain
• Fruity-smelling breath
• Loss of consciousness

DKA requires immediate medical care and often hospitalization. Without treatment, the condition can lead to coma or death.

Because the Omnipod system is designed to deliver insulin continuously, patients may depend on the device to prevent precisely this type of complication. When the system fails due to a manufacturing defect, the risk of serious harm increases.

Reported Adverse Events Linked to the Recall

Federal safety alerts indicate that at least eighteen serious adverse events involving high blood glucose levels have been associated with the recalled pods.

These incidents demonstrate that the manufacturing defect was not merely theoretical. Patients using the defective pods experienced significant health complications linked to insufficient insulin delivery.

While Insulet has stated that the issue has been corrected in newer production batches, individuals who used pods from the affected lots may have already suffered harm before the recall notice was issued.

Medical device recalls often raise important questions about when the defect was first identified, how quickly corrective action was taken, and whether adequate warnings were provided to users and healthcare providers.

Patients who experienced complications such as severe hyperglycemia or diabetic ketoacidosis may wish to investigate whether the recalled pods played a role in their injuries.

Legal Rights of Patients Injured by Defective Medical Devices

Manufacturers of medical devices have a legal duty to ensure that their products are reasonably safe for their intended use. This responsibility includes properly designing devices, maintaining quality control during manufacturing, and monitoring products after they enter the market.

When a defect in the manufacturing process leads to a dangerous product entering the marketplace, injured patients may be able to pursue compensation through a product liability claim.

These claims may involve allegations such as:

• Defective manufacturing
• Failure to ensure quality control
• Failure to adequately warn consumers
• Negligent product testing

Individuals harmed by defective medical devices may seek compensation for:

• Medical expenses
• Emergency hospital care
• Ongoing treatment costs
• Lost income
• Long-term health complications
• Pain and suffering

Product liability lawsuits also play an important role in holding manufacturers accountable and encouraging stronger safety standards.

Lawsuit FAQs

Can I file a lawsuit if a defective Omnipod pod caused high blood sugar or hospitalization?

Yes. If a defective insulin delivery pod prevented insulin from reaching your body and caused serious complications such as severe hyperglycemia or diabetic ketoacidosis, you may have a legal claim against the manufacturer.

What evidence is needed in a defective insulin pump case?

Evidence may include medical records, device lot numbers, recall notices, pharmacy records, and documentation showing hospitalization or treatment related to high blood glucose levels. Medical experts may also review how the device malfunction contributed to the injury.

What types of injuries are linked to defective insulin delivery systems?

Potential injuries include diabetic ketoacidosis, severe hyperglycemia, hospitalization, organ complications, neurological effects from prolonged high glucose levels, and long-term diabetes complications caused by delayed insulin treatment.

How do I know if my Omnipod was part of the recall?

Affected lots can be identified using information provided by the manufacturer and the FDA. Patients may also check packaging, medical device records, or pharmacy supply information. An attorney can help investigate whether a recalled device was used.

What compensation may be available in a defective medical device case?

Compensation may include reimbursement for hospital bills, ongoing medical treatment, lost wages, reduced earning ability, and physical and emotional suffering caused by the injury.

How long do I have to file a claim?

The time limit depends on state law. Each state has statutes of limitations that determine how long a patient has to file a product liability lawsuit. Acting quickly helps preserve important evidence.

Do I have to pay legal fees upfront?

Most product liability cases are handled on a contingency basis. This means clients do not pay attorney fees unless compensation is recovered.

Contact Parker Waichman LLP For a Free Case Review

If you or a loved one experienced severe high blood glucose levels, diabetic ketoacidosis, or other serious complications while using an Omnipod insulin delivery system, you may have legal options.

Parker Waichman LLP is investigating claims involving defective insulin delivery pods. The firm offers free consultations to help injured patients understand their rights and determine whether they may qualify to pursue compensation.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today to speak with a member of the legal team and learn more about your options. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.